Listing on the Stockholm Stock Exchange O List

Listing on the Stockholm Stock Exchange O List Series A shares and paid-up subscription rights (BTA) in BioPhausia AB (publ) will be listed on the Stockholm Stock Exchange O List, commencing March 25, 1998. Subscription rights will be traded on the Stockholm Stock Exchange in the period March 25 to April 3. Aros Securities is advising BioPhausia in connection with share issue and the company's listing. Uppsala, March 24, 1998 Based on its contact network and know-how, primarily in connective- tissue biology, BioPhausia is developing products for licensing to well-established pharmaceutical companies with strong marketing organizations. The project portfolio includes RescueFlow®, a resuscitation solution (registration phase), Krillase® for the debridement of chronic wounds (clinical phase III), and preclinical projects in the tumor and trauma treatment areas. Please contact the President, Stellan Lind, for further information. Tel. +46-18-34 99 00